Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Helpap

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Histology and Histopathology|March 14, 2009
Modified Gleason grading. An updated reviewBurkhard Helpap, Lars Egevad
Analytical and Quantitative Cytopathology and Histopathology|July 2, 2016
Significance of Number and Localization of Positive Core Biopsies for the Identification of Prostate Cancer Eligible for Active SurveillanceBurkhard Helpap, Daniel Ringli, Heidrun Gevensleben
Pathology, Research and Practice|February 20, 2013
The heterogeneous Gleason 7 carcinoma of the prostate: analyses of low and high grade (risk) carcinomas with criteria of the International Society of Urological Pathology (ISUP)Burkhard Helpap, Daniel Ringli, David Adler, et al.
Urologia Internationalis|September 9, 2015
The Value of Prognostic Grouping of Prostatic Carcinomas for Urologists and PathologistsBurkhard Helpap, Daniel Ringli, Jürgen Breul, et al.
European Urology|October 24, 2003
Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patientsJens Köllermann, Markus Müller, Carsten Goessl, et al.
Urology|August 30, 2003
Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomyJens Köllermann, Jörg Caprano, Anke Budde, et al.
European Urology|December 12, 2003
Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched-pair analysisJens Köllermann, Werner Hopfenmüller, Jörg Caprano, et al.
Urologia Internationalis|October 26, 2012
Significance of Gleason grading of low-grade carcinoma of the prostate with therapeutic option of active surveillanceBurkhard Helpap, Glen Kristiansen, Jens Köllermann, et al.
Pathology Oncology Research : POR|November 14, 2015
The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate CancerBurkhard Helpap, Daniel Ringli, Jens Tonhauser, et al.
BMC Urology|June 29, 2006
Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancerJens Kollermann, Carsten Kempkensteffen, Burkhard Helpap, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Histology and Histopathology|March 14, 2009
Modified Gleason grading. An updated reviewBurkhard Helpap, Lars Egevad
Analytical and Quantitative Cytopathology and Histopathology|July 2, 2016
Significance of Number and Localization of Positive Core Biopsies for the Identification of Prostate Cancer Eligible for Active SurveillanceBurkhard Helpap, Daniel Ringli, Heidrun Gevensleben
Pathology, Research and Practice|February 20, 2013
The heterogeneous Gleason 7 carcinoma of the prostate: analyses of low and high grade (risk) carcinomas with criteria of the International Society of Urological Pathology (ISUP)Burkhard Helpap, Daniel Ringli, David Adler, et al.
Urologia Internationalis|September 9, 2015
The Value of Prognostic Grouping of Prostatic Carcinomas for Urologists and PathologistsBurkhard Helpap, Daniel Ringli, Jürgen Breul, et al.
European Urology|October 24, 2003
Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patientsJens Köllermann, Markus Müller, Carsten Goessl, et al.
Urology|August 30, 2003
Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomyJens Köllermann, Jörg Caprano, Anke Budde, et al.
European Urology|December 12, 2003
Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched-pair analysisJens Köllermann, Werner Hopfenmüller, Jörg Caprano, et al.
Urologia Internationalis|October 26, 2012
Significance of Gleason grading of low-grade carcinoma of the prostate with therapeutic option of active surveillanceBurkhard Helpap, Glen Kristiansen, Jens Köllermann, et al.
Pathology Oncology Research : POR|November 14, 2015
The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate CancerBurkhard Helpap, Daniel Ringli, Jens Tonhauser, et al.
BMC Urology|June 29, 2006
Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancerJens Kollermann, Carsten Kempkensteffen, Burkhard Helpap, et al.
Pageof 3